Next-generation sequencing reveals relapse and leukemia-free survival risks in newly diagnosed acute myeloid leukemia treated with CAG regimen combined with decitabine

Next-generation sequencing reveals relapse and leukemia-free survival risks in newly diagnosed acute myeloid leukemia treated with CAG regimen combined with decitabine

Background: Acute myeloid leukemia (AML) is a heterogeneous hematopoietic malignancy whose prognosis is associated with several biomarkers. Decitabine, a deoxyribonucleic acid (DNA) methyltransferase (DNMT) inhibitor, combined with cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimul...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Sai Huang, Peng Chen, Lu Wang, Lingmin Xu, Nan Wang, Fei Li, Liping Dou, Daihong Liu
स्वरूप: लेख
भाषा:English
प्रकाशित: Elsevier 2024-04-01
श्रृंखला:Cancer Pathogenesis and Therapy
विषय:
Acute myeloid leukemia
Next-generation sequencing
Prognosis
DNA methyltransferase
Chemotherapy
ऑनलाइन पहुंच:http://www.sciencedirect.com/science/article/pii/S2949713223000848

इंटरनेट

http://www.sciencedirect.com/science/article/pii/S2949713223000848

समान संसाधन